Sarvagunaushdhi Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
as on 24-10-2024
- Paid Up Capital ₹ 0.19 M
as on 24-10-2024
- Company Age 7 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue 69.02%
(FY 2023)
- Profit 869.01%
(FY 2023)
- Ebitda -543.32%
(FY 2023)
- Net Worth 236.34%
(FY 2023)
- Total Assets 185.82%
(FY 2023)
About Sarvagunaushdhi
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.19 M, as per Ministry of Corporate Affairs (MCA) records.
Kusum Sharma and Rashmi Gupta serve as directors at the Company.
- CIN/LLPIN
U51909DL2017PTC324616
- Company No.
324616
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Oct 2017
- Date of AGM
26 May 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
- Apps
What products or services does Sarvagunaushdhi Private Limited offer?
Sarvagunaushdhi Private Limited offers a wide range of products and services, including Cosmetics, Hair & Beauty Products, Skin Care Cosmetics, Ayurvedic & Herbal Health Supplement, Herbal Juice, Common Disease Medicines, Cough Syrup, Sexual Wellness Products, Female Hygiene Products & Test Kits, Facial Mask, Hand Sanitizers & Personal Hygiene.
Who are the key members and board of directors at Sarvagunaushdhi?
Board Members(2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Kusum Sharma | Director | 17-Sep-2022 | Current |
Rashmi Gupta | Director | 06-Oct-2017 | Current |
Financial Performance and Corporate Structure Insights of Sarvagunaushdhi.
Sarvagunaushdhi Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 69.02% increase. The company also saw a substantial improvement in profitability, with a 869.01% increase in profit. The company's net worth Soared by an impressive increase of 236.34%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Sarvagunaushdhi?
In 2023, Sarvagunaushdhi had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sarvagunaushdhi?
Sarvagunaushdhi has a workforce of 15 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sarvagunaushdhi, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sarvagunaushdhi's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.